The Fragmentation of Innovation: Why Niche Markets Matter This SummerGlobal Report·5 minutes agoSTDN-5.47%CAPR-0.66%
Beyond the Mega-Caps: AI Patent Wars, Housing Slowdowns, and the Market's Messy MiddleGlobal Report·1 day ago, 04:13 AMNLST+0.81%HKPD+10.33%
Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis StudyTip Ranks·2 days ago, 04:48 PMBJDX-9.65%
Bluejay Diagnostics initial beneficial ownership statement names Bank of America as 10% ownerPUBT·2 days ago, 12:30 PMBJDX-9.65%BAC+1.26%
Bluejay Diagnostics announces SYMON-II sepsis study enrollment completionPUBT·Jul 21 at 05:32 AMBJDX-9.65%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Jul 20 at 07:05 AMBRNS+0.32%VBIO+3.85%
MedTech Restructuring Accelerates Against the Backdrop of Macro Capital PressuresGlobal Report·Jul 19 at 04:12 AMDHR-0.52%AVTR+0.79%
Compute, Security, and Capital Abstraction: The 2026 Infrastructure Value ChainGlobal Report·Jul 18 at 04:12 AMPURR-4.92%SRXH0.00%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·Jul 17 at 04:05 PMADVB+13.11%ALPS-1.08%
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·Jul 14 at 07:05 AMBJDX-9.65%PLRZ-4.11%
HRT Financial LP sells 34,938 Bluejay Diagnostics shares for $48,913.20PUBT·Jul 13 at 02:15 PMBJDX-9.65%
Bluejay Diagnostics initial beneficial ownership filing shows HRT Financial LP stake of 126,993 sharesPUBT·Jul 13 at 02:03 PMBJDX-9.65%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jul 9 at 07:05 AMAPVO+0.46%IONS+1.22%
